Christopher Starr, MD
Disclosures: Consulting Fee-Allergan-Other_Role-Consultant|Consulting Fee-Johnson and Johnson-Other_Role-Consultant|Consulting Fee-TearLab-Other_Role-Consultant|Consulting Fee-Bruder-Other_Role-Consultant|Consulting Fee-Kala-Other_Role-Consultant|Consulting Fee-Novartis-Other_Role-Consultant|Consulting Fee-Blephex-Other_Role-Consultant|Consulting Fee-Sun-Other_Role-Consultant|Consulting Fee-Eyevance-Other_Role-Consultant|Consulting Fee-Tarsus-Other_Role-Consultant|Consulting Fee-dompe-Other_Role-Consultant|Consulting Fee-Oyster Point-Other_Role-Consultant|Consulting Fee-Quidel-Other_Role-Consultant|Consulting Fee-Essiri Labs-Other_Role-Consultant, stock options|Ownership Interest-Visionology-Other_Role-consultant, stock options - 07/28/2021
No Bio Available.